Download or read book The Egyptian Pharmaceutical Industry written by and published by . This book was released on 2001 with total page 56 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book The Pharmaceutical Market in Egypt written by Susan Watkins and published by . This book was released on 2012 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: Egypt is emerging as an important pharmaceutical market. Executives must understand the backdrop of political unrest, laws governing intellectual property rights, problems with counterfeits, and pricing reforms, to make the most of the opportunities.

Download or read book The Pharmaceutical Industry in Egypt written by Heba Ahmed Handoussa and published by . This book was released on 1974 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: This thesis is an assessment of the performance of the Egyptian pharmaceutical industry in the context of am international market for drugs which is dominated by the operation of multinational firms. Chapter I begins with an analysis of the determinants of demand for drugs, followed by a definition of terms and a classification of pharmaceutical products according to their therapeutic usage and the technical processes involved in their manufacture. Section 3 of Chapter 1 describes the structure of the international market for drugs, exploring the major factors responsible for a significant rate of concentration in the industry, an excessive amount of expenditure on innovations and promotion, and unreasonably high prices. Section 4 of Chapter I singles out the specific problems concerning devleloping countries in their acquisition of drugs and examines the arguments so far presented on the subject. Chapter II traces the development of the Egyptian pharmaceutical industry from its early start in a free enterprise environment and through the 1950s when government control gradually became total. Section 1 of Chapter III describes the changing pattern of supply of drugs by multinational firms in various markets. This is followed in Section 2 by a detailed analysis of the operation of multinational firms in Egypt, with special emphasis on their comparative gain from particular forms of investment. Section 3 of Chapter III identifies the costs and benefits derived by the Egyptian economy from the operation of multinational pharmaceutical firms, with a quantitative judgement of figures obtained for the two major kinds of foreign operations in Egypt: subsidiaries and license agreements. Chapter IV gives an assessment of the performance of the nationalised domestic sector of the Egyptian pharmaceutical industry over the period 1960 to 1970/71, using indices for production, value added and profits as basic indicators. The price structure for drugs is also examined for its influence on the profitability of domestic firms and on the production indices for the industry. In Section 3 of Chapter IV the policy of GOPCA, the centralised government body in control of the Egyptian market for drugs, is assessed for its influence on the present and future growth of the industry. Section 4 of Chapter IV is devoted to a close study of the problems which the industry has experienced with backward integration, as portrayed in the operation of the primary producing pharmaceutical chemicals plant, El Nasr. Chapter V summarises the results of this study.

Download or read book The Egypt EU Partnership Agreement and the Egyptian Pharmaceutical Sector written by Arvind Subramanian and published by . This book was released on 1997 with total page 40 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book The Illusive Trade off written by Basma Abdelgafar and published by . This book was released on 2006-12-30 with total page 256 pages. Available in PDF, EPUB and Kindle. Book excerpt: The Egyptian pharmaceutical industry serves as a case study for understanding the impact of the global intellectual property regime in this fascinating new addition to the University of Toronto Press Studies in Comparative Political Economy and Public Policy Series. The Illusive Trade-off examines the Egyptian pharmaceutical industry within a broader context of intellectual property policy making and the multilateral agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs). Basma Abdelgafar offers a fascinating discussion of Egypt's role in the trade negotiations that led to the establishment of the World Trade Organization, and makes the case that predominant perspectives on intellectual property rights are based on the false assumption that the innovation process is discrete and segmented. Abdelgafar contends that, in fact, innovation relies upon diffusion, and that inappropriately strong property rights interfere with this process. She uses the case of Egypt's pharmaceutical industry to argue that we must consider relevant aspects of individual countries' systems of innovation as well as public health, if we are to adequately understand the implication of stronger patent protection for the pharmaceutical industries of developing nations. The Illusive Trade-off is an original and important study crossing the disciplines of political science, law, public policy, and public health.

Download or read book The Egyptian Pharmaceutical Industry written by Khaled Ahmed Fouad Sherif and published by . This book was released on 1986 with total page 462 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book The Pharmaceutical Supply of Brand and Generic Medicines in Different Rural and Urban Areas of Egypt written by Yasin M. Ragaey Afify and published by . This book was released on 2016 with total page 166 pages. Available in PDF, EPUB and Kindle. Book excerpt: Abstract: Medicines are an important intervention for protecting public health. While medicines have brand and generic type products, those used for treating non-communicable diseases are used by patients for life. The pharmaceutical market is not a competitive market with asymmetric flow of information. Equal access to both types of medicines is part of equal access to health care in different socioeconomic areas. Patients with non-communicable diseases should own their choice of whether brand or generic medicines for their treatment not the market supply that dictates their consumption. In this thesis, we used data for availability of 39 medicines treating non-communicable diseases selected based on some inclusion criteria. Our hypothesis assumed social equity that presumes equal access to both medicine types in varying rural and urban areas where population having chronic conditions have to acquire their treatments for life. Data was modeled and logistic regression was used. Results were produced using statistical software; both SPSS and R. Primary findings show that rural and urban areas have different pattern of market supply for both brand and generic medicine types. In the same settings of a socioeconomic area, the probability of supply of brand rather than generic medicines increases by the increase in price. Social health insurance coupled by pharmaceutical Track and Trace system and combined pricing mechanisms should be in place to insure equilibrium between market supply and equal access to medicines. Patients with non-communicable diseases in different urban and rural areas in Egypt should be left to consume their medicine type at their choice. Guidelines for promotion of prescription medicines, guidelines for prescribing practices should be in place to improve the market equilibrium.

Download or read book Pharmaceutical Prices in the 21st Century written by Zaheer-Ud-Din Babar and published by Springer. This book was released on 2014-12-05 with total page 410 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book provides an overview of the global pharmaceutical pricing policies. Medicines use is increasing globally with the increase in resistant microbes, emergence of new treatments, and because of awareness among consumers. This has resulted in increased drug expenditures globally. As the pharmaceutical market is expanding, a variety of pharmaceutical pricing strategies and policies have been employed by drug companies, state organizations and pharmaceutical pricing authorities.

Download or read book How to Boost Egyptian Pharmaceutical Exports written by Shereen Mohamed Abdelgawad and published by . This book was released on 2023 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: Abstract: One of the key pillars of the Egyptian economic reform adopted in 2016 was to raise the export rate. Since the pharmaceutical sector is one of Egypt's most established industries, the Egyptian government worked on a national plan to support the exports of medicines. Despite the impact of pharmaceutical exports on economic growth, there was limited research on this topic in Egypt. This study aims to provide a better knowledge of the problems of exporting medications in Egypt by investigating barriers and Covid-19 influence on pharmaceutical export. In-depth semi-structured interviews with representatives from pharmaceutical exporting companies have been conducted. The study's main findings are divided into four groups; problems connected to the export country, such as procedural restrictions in the regulatory bodies; restrictions related to importing countries, such as information barriers and drug smuggling; issues related to the company, such as the qualification of the manufacturing site and the staff; problems with intellectual property rights. The data also demonstrated that the Egyptian government exerted significant efforts to support export. Finally, some recommendations for the government and companies are suggested to overcome these barriers and enhance pharmaceutical exports.

Download or read book Pharmaceutical Promotion and GP Prescription Behaviour written by Frank A. G. Windmeijer and published by . This book was released on 2004 with total page 54 pages. Available in PDF, EPUB and Kindle. Book excerpt: "Identification of price effects is obtained by the introduction of the Pharmaceutical Prices Act, which established that Dutch drugs prices became a weighted average of the prices in surrounding countries after June 1996. We conclude that, on average, GP drug price sensitivity is small, but adversely affected by promotion."--Editor.

Download or read book Foreign Direct Investments in the Pharmaceutical Industry in Egypt written by Marina Mourad Moris Abdou and published by . This book was released on 2019 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Egypt Medical and Pharmaceutical Industry Handbook written by IBP USA Staff and published by . This book was released on 2009-03-20 with total page 300 pages. Available in PDF, EPUB and Kindle. Book excerpt: Egypt Medical & Pharmaceutical Industry Handbook

Download or read book Transnational Corporations in the Pharmaceutical Industry of Developing Countries written by and published by . This book was released on 1984 with total page 248 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book The New Political Economy of Pharmaceuticals written by Hans Löfgren and published by Springer. This book was released on 2016-04-30 with total page 247 pages. Available in PDF, EPUB and Kindle. Book excerpt: Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs.

Download or read book The Global Politics of Pharmaceutical Monopoly Power written by Ellen F. M. 't Hoen and published by . This book was released on 2009 with total page 136 pages. Available in PDF, EPUB and Kindle. Book excerpt: In The Global Politics of Pharmaceutical Monopoly Power, researcher and global advocate Ellen 't Hoen explains how new global rules for pharmaceutical patenting impact access to medicines in the developing world. The book gives an account of the current debates on intellectual property, access to medicines, and medical innovation, and provides historical context that explains how the current system emerged. This book supports major policy changes in the management of pharmaceutical patents and the way medical innovation is financed in order to protect public health and, in particular, promote access to essential medicines for all. The Open Society Institute provided support to translate this report into Russian.

Download or read book WHO guideline on country pharmaceutical pricing policies written by and published by World Health Organization. This book was released on 2020-09-29 with total page 70 pages. Available in PDF, EPUB and Kindle. Book excerpt: In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.

Download or read book The Pharmaceutical Industry and Dependency in the Third World written by Gary Gereffi and published by Princeton University Press. This book was released on 2017-03-14 with total page 307 pages. Available in PDF, EPUB and Kindle. Book excerpt: Gary Gereffi first explains how foreign corporations took over the flourishing Mexican steroid industry in the 1950s and 1960s and thwarted the country's later attempts to establish a more equitable distribution of industry benefits. In this valuable theoretical contribution Professor Gereffi uses the Mexican industry's plight as a crucial-case test for dependency theory. Originally published in 1983. The Princeton Legacy Library uses the latest print-on-demand technology to again make available previously out-of-print books from the distinguished backlist of Princeton University Press. These editions preserve the original texts of these important books while presenting them in durable paperback and hardcover editions. The goal of the Princeton Legacy Library is to vastly increase access to the rich scholarly heritage found in the thousands of books published by Princeton University Press since its founding in 1905.